International Biotechnology Trust PLC 13F Holdings · last filed Q3 2023
International Biotechnology Trust PLC reported 65 securities worth $296.85M in its SEC 13F filing for Q3 2023 (period ended 2023-09-30). Top holdings: AMGN (7.17%), INCY (6.97%), GILD (5.90%). Among its top 25 positions this quarter: 12 added, 8 trimmed.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | AMGN | AMGEN INC COM | $21.3M | 7.17% | 79,246 | Trimmed |
| 2 | INCY | INCYTE CORP INC COM | $20.7M | 6.97% | 358,454 | Hold |
| 3 | GILD | GILEAD SCIENCES INC COMMO | $17.5M | 5.90% | 233,584 | Added |
| 4 | ITCI | INTRA-CELLULAR THERAPIES | $16.5M | 5.57% | 317,856 | Added |
| 5 | BMRN | BIOMARIN PHARMACEUTICAL I | $13.6M | 4.58% | 153,656 | Added |
| 6 | SUPN | SUPERNUS PHARMACEUTICALS | $11.8M | 3.96% | 426,500 | Trimmed |
| 7 | VERA | VERA THERAPEUTICS | $10.4M | 3.50% | 758,355 | Trimmed |
| 8 | BIIB | BIOGEN INC COMMON STOCK | $10.3M | 3.48% | 40,200 | Added |
| 9 | HRMY | Harmony Biosciences Holdi | $10.3M | 3.47% | 314,500 | Trimmed |
| 10 | MRTX | MIRATI THERAPEUTICS INC C | $9.4M | 3.17% | 216,000 | Trimmed |
| 11 | RARE | ULTRAGENYX PHARMACEUTICAL | $8.9M | 3.00% | 250,052 | Added |
| 12 | QURE | UNIQURE N.V. COM EUR0.05 | $8.3M | 2.81% | 1.2M | Added |
| 13 | AUPH | AURINIA PHARMACEUTICALS I | $8.1M | 2.72% | 1.0M | Added |
| 14 | UTHR | UNITED THERAPEUTICS CORP | $7.7M | 2.58% | 33,959 | Trimmed |
| 15 | VRTX | VERTEX PHARMACEUTICALS IN | $7.3M | 2.46% | 21,000 | Hold |
| 16 | REGN | REGENERON PHARMACEUTICALS | $7.3M | 2.45% | 8,847 | Trimmed |
| 17 | ILMN | ILLUMINA INC COM | $6.9M | 2.34% | 50,500 | Hold |
| 18 | ALNY | ALNYLAM PHARMACEUTICALS I | $6.5M | 2.20% | 36,800 | Trimmed |
| 19 | AMLX | AMYLYX PHARMS. | $5.4M | 1.82% | 295,000 | Added |
| 20 | KRYS | KRYSTAL BIOTECH INC COM | $5.3M | 1.80% | 46,092 | Added |
| 21 | KRTX | KARUNA THERAPEUTICS INC C | $5.2M | 1.74% | 30,500 | Added |
| 22 | AXSM | AXSOME THERAPEUTICS INC. | $4.1M | 1.37% | 58,300 | Hold |
| 23 | ERAS | ERASCA INC COM | $3.8M | 1.28% | 1.9M | Added |
| 24 | ACAD | ACADIA PHARMACEUTICALS IN | $3.7M | 1.26% | 179,702 | Added |
| 25 | RVNC | REVANCE THERAPEUTICS INC | $3.3M | 1.11% | 288,726 | Hold |
Source: SEC Form 13F filings · as of 2023-09-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR